UPPSALA, Sweden, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the achievement of more than one thousand peer-reviewed publications citing ...

The Olink PEA technology enables dual antibody recognition of the target proteins and high-fidelity DNA hybridization and detection.

Olink also has other PCR-based platforms that begin to narrow the focus of PEA technology to individual areas. In particular, they allow for targeting proteins related to particular diseases or ...

Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute ...

Olink Holding AB (publ) (OLK) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET CompanyParticipants Jon Heimer - CEO Oskar Hjelm - CFO Carl Raimond - CCO Jan Medina - VP, IR & Capital ...

Discovery will offer Olink ® PEA technology to complement their genomic, cell biology, and tissue biomarker services, providing multi-omic analyses that inform and accelerate decision-making ...